We investigated the effects of dietary trans fatty acids, PUFA, and SFA on body and liver fat content, liver histology, and mRNA of enzymes involved in fatty acid metabolism. LDL receptor knockout weaning male mice were fed for 16 wk with diets containing 40% energy as either trans fatty acids (TRANS), PUFA, or SFA. Afterwards, subcutaneous and epididymal fat were weighed and histological markers of nonalcoholic fatty liver disease (NAFLD) were assessed according to the Histological Scoring System for NAFLD. PPARa, PPARg, microsomal triglyceride transfer protein These results demonstrate the role of trans fatty acid intake on the development of key features of metabolic syndrome.
Introduction
The intake of fat-rich diets and a sedentary lifestyle are related to the epidemic of obesity in Western societies. Body weight excess and abdominal obesity predispose to insulin resistance, dyslipidemia, hypertension, and a proinflammatory and prothrombotic status, which are linked to the development of premature atherosclerotic cardiovascular disease and type 2 diabetes mellitus (1) .
Nonalcoholic fatty liver disease (NAFLD) 7 is a clinical and pathological condition whose severity can range from mild steatosis to nonalcoholic steatohepatitis (NASH) and even to cirrhosis and hepatocellular carcinoma (2) in patients without a history of alcohol abuse. The prevalence of NAFLD is rapidly increasing, ranging from 15 to 25% in the general population (3) . Recently, a strong association between metabolic syndrome and NAFLD was reported;~90% of NAFLD cases concurrently present 1 or more features of metabolic syndrome, whereas 30% present all features of metabolic syndrome (4) .
Although the etiology of NAFLD is not fully understood, accumulation of fat in the liver has been ascribed to diverse fatty acid metabolic abnormalities, including increased hepatic lipogenesis, impaired mitochondrial fatty acid oxidation, and increased triglyceride (TG) content of VLDL particles (5, 6) . Additionally, fatty liver can be associated with local oxidative stress, lipid peroxidation, and tumor necrosis factor-a production that may be critical to liver injury, inflammation, fibrosis, and the development of NASH (6, 7) .
The individual roles of various nutritional and metabolic factors in the pathogenesis and natural history of NAFLD are still incompletely understood. One key contributor could be insulin resistance, regarded by some as the hallmark and causal factor of NAFLD, although its occurrence is not obligatory for NAFLD (8, 9) . Individuals with uncomplicated steatosis and NASH have been studied to discern common dietary patterns and macronutrient intake. Whereas some studies revealed elevated carbohydrate and fat intake, scientific and clinical consensus is lacking. Dietary assessment cannot reveal lipotoxicity per se (10) .
Other studies have shown that both quantity and quality of dietary fat influences liver fatty acid synthesis (11) (12) (13) and insulin sensitivity (14, 15) . Dietary fatty acids can induce insulin resistance (16) and raise the risk of cardiovascular disease (17) . Furthermore, elevated intake of trans fatty acids (18) and dietary SFA are related to the incidence of coronary atherosclerotic disease (19) . The proatherogenic effect of the trans fatty acids is in part attributed to reduced plasma HDL cholesterol (HDL-C) and increased LDL cholesterol, TG, and lipoprotein (a) (18) (19) (20) . However, little is known about the influence of trans fatty acids on hepatic lipid metabolism. In mice, intake of trans fatty acids induced fat accumulation in the liver that resembled NASH (21); however, PUFA were not included for comparison and the authors did not evaluate hepatic genes involved in fat accumulation (21) .
LDL receptor knockout (LDLr-KO) mice have a plasma lipoprotein profile that mimics that of humans. When fed a highfat diet, these mice develop atherosclerosis, weight gain, and other features of metabolic syndrome such as hypertriglyceridemia, decreased HDL, hyperinsulinemia, and insulin resistance (22) . Therefore, we chose this murine model to compare the effects of high-fat diets enriched with 3 different fatty acids, trans (TRANS), PUFA, and SFA fatty acid, on the development of NAFLD.
Materials and Methods
Mouse models and diet. LDLr-KO weaning male mice (C57BL/6J; Jackson Laboratory) were fed for 16 wk with 1 of 3 high-fat diets (40% of energy as fat) enriched with trans fatty acids (TRANS; n = 13), PUFA (n = 14), or SFA (n = 14). Diets were prepared by Nutriexperimental and the composition complied with the recommendations of the AIN (23) . The fatty acid compositions of the fats used in the diets are shown on Table 1 .
After weaning, male LDLr-KO mice were housed in a temperaturecontrolled environment (12-h-light/-dark cycle) and were allowed ad libitum access to food and water. Mice were weighed weekly and food intake was estimated daily by weighing the food offered and the residual food from the previous feeding. After a 16-wk period, mice were feeddeprived for 12 h and anesthetized with ketamine (100 mg/kg, intraperitoneal, Ketalar; Parke-Davis) and xylazine (10 mg/kg, intraperitoneal, Rompum; Bayer). Blood was then drawn from the subclavian vein. All animal experiments and care were conducted in accordance with the Ethics Committee of the Faculty of Medical Sciences of the University of Sã o Paulo.
Livers and epididymal fat pads were dissected, weighed, and immediately frozen. For later determination of subcutaneous adipose tissue, the remaining carcass was frozen and stored at 2208C until further analysis.
Blood sampling and lipoprotein profile. Plasma was separated after centrifugation and samples were stored at 2808C. The following analyses were performed with enzymatic kits: plasma cholesterol (Cholesterol CHOD-PAP 1489232), TG (Triglyceride GPO-PAP 11488872), glucose (Glucose PAP 84 Labtest Diagnostics, MG), alanine aminotransferase (ALT) (ALT/GTP Liquiform 108, Labtest Diagnostics), and aspartate aminotransferase (AST) (AST/GOT Liquiform 109, Labtest Diagnostics). Insulin was measured using an ELISA (Alpco Diagnostics). The homeostasis model assessment of insulin resistance (HOMA IR ) index was calculated with glucose and insulin concentration obtained in the feed-deprived state using the following formula: glucose (mg/dL) 3 insulin (mU/mL)/405. The plasma lipoprotein profile was determined by fast protein liquid chromatography. Whole plasma (100 mL) was injected onto a HR 10/30 30-cm Superose 6 column (Pharmacia Biotech) and run at a constant flow of 0.5 mL/min with Tris buffer (10 mmol/L Tris, 150 mmol/L NaCl, 1 mmol/L EDTA, and 0.03% NaN 3 ), pH 7.4. Fractions were collected and pooled according to the elution times expected for VLDL, LDL, and HDL. Aliquots of isolated lipoprotein fractions were used for enzymatic measurement of cholesterol and TG in a Cobas Mira analyzer (F. Hoffman-La Roche).
Subcutaneous adipose tissue extraction. Subcutaneous adipose tissue was extracted after homogenization under mild alkaline hydrolysis. Briefly, after removing the head, the carcasses were heated (908C) in ethanol (20 mL, 95%, NaOH, 2 mL at 10 mol/L) until complete dissolution of the tissues. The samples were then acidified with HCl (10 mol/L) followed by lipid extraction with hexane (3 3 40 mL). After solvent evaporation, lipids were diluted in hexane, transferred to preweighed glass shells, and completely evaporated at room temperature. The glass shells were then weighed to extrapolate the weight of lipids.
Histological analysis and grading of the NAFLD activity. Liver tissue samples of each animal were fixed in 4% formaldehyde and processed for histological analysis with hematoxylin/eosin and Masson's Trichrome stains. Histological variables were blindly scored by one of the authors (E.S.M.) using a scoring system adapted from the NASH activity score in accordance with the Pathology Committee of the NASH Clinical Research Network (24) . This system numerically rates macrosteatosis (0-3), lobular inflammatory changes (0-3), and hepatocyte ballooning (0-2) and fibrosis (24) (25) (26) .
Liver lipid concentrations. Measurement of liver cholesterol and TG was performed as previously described (27) . Briefly,~200 mg of tissue (wet weight) was homogenized and lipids were extracted in a chloroform:methanol (2:1) solution (6 mL). Phases were separated by the addition of 0.05% H 2 SO 4 . Chloroform (1 mL, 0.5% Triton X-100) was then added to the lower phase and dried under nitrogen at room temperature. The tubes were rinsed with chloroform and dried again. Deionized water (1 mL) was added, tubes were shaken in a water bath (378C for 15 min), vortexed, and subsequently used for the enzymatic determination of lipid content.
Liver RNA analysis. Liver tissue total RNA was extracted using Trizol (Invitrogen Life Technologies) according to the manufacturer's recommendations. RNA content was determined spectrophotometrically and RNA integrity verified by visualization of the 28S and 18S RNA bands in a 1% agarose gel stained with ethidium bromide. Transcription levels of PPARa, PPARg, microsomal TG transfer protein (MTP), carnitine palmitoyl transferase (CPT-1), and sterol regulatory element binding protein 1-c (SREBP-1c) were determined by quantitative RT-PCR, which was carried out in a Rotor-Gene RG-3000 (Corbett Research) using the SuperScript III Platinum One-Step Quantitative RT-PCR system (Invitrogen Life Technologies) according to the manufacturer's instructions. Primers were designed using the Primer3 Plus (http://primer3. sourceforge.net). The sense and antisense primers for each transcript were as follows: b-actin, TGTTACCAACTGGGACGACA and GGGGT-GTTGAAGGTCTCAAA; PPARa, ATGCCAGTACTGCCGTTTTC and TTGCCCAGAGATTTGAGGTC; PPARg, CATAAAGTCCTTCCCGC-TGA and GAAACTGGCACCCTTGAAAA; MTP, CCTCTTGGCA-GTGCTTTTTC and ATTTTGTAGCCCACGCTGTC; CPT-1, TGCCT-CTATGTGGTGTCCAA and TCAAACAGTTCCACCTGCTG; SREBP-1c, GCGCTACCGGTCTTCTATCA and GGATGTAGTCGATGGCCTTG.
Values of PPARa, PPARg, MTP, CPT-1, and SREBP-1 mRNA were normalized by corresponding values of housekeeping b-actin mRNA and additionally normalized to the mean value control livers from mice fed a regular-fat diet (Nuvilab-CR1, Nuvital). These animals were utilized to determine basal conditions. To evaluate the amplification efficiency of each target gene and b-actin gene, standard curves were constructed from a control liver RNA sample using duplicate serial dilutions with 5 different RNA concentrations (500, 100, 20, 4, and 0.8 mg/L). Relative quantification was calculated using the 2 2DDCT method (28) for PPARg and SREBP-1 genes based on their equivalent amplification efficiency with b-actin. The mathematical model described (29) was used to evaluate the relative expression ratio of PPARa, MTP, and CPT-1 to b-actin. Amplification of PPARa, PPARg, MTP, CPT-1, SREBP-1c, and housekeeping control genes was conducted in duplicate for each sample.
Interassay
Statistical analysis.
Results are expressed as means 6 SD. Statistical analysis for the data that passed the normality test was performed using 1-way ANOVA followed by the post hoc Newman-Keuls multiple comparison test for pair wise comparisons. AST and ALT were analyzed by nonparametric Kruskal-Wallis tests. A value of P , 0.05 was considered significant. The data were analyzed with the software GraphPad Prism 4 (GraphPad Software).
Results
Food intake did not differ among the groups, even though mice fed the TRANS diet gained less weight than those fed the PUFA (16%) and SFA (11%) diets. Moreover, mice in the TRANS group had~37% and 36% less subcutaneous fat compared with mice in the PUFA and SFA groups, respectively. The epididymal fat pad content, which roughly mimics visceral fat in humans, was also lower in mice fed the TRANS diet (Table 2) . However, liver weight of the TRANS-fed mice was 66% and 61% higher as compared with PUFA-and SFA-fed mice, respectively ( Table  2 ; Supplemental Fig. 1A ). Plasma AST and ALT levels did not differ among the groups (Table 2) .
Liver histology and lipid concentrations. Liver total cholesterol (TC) and TG concentrations were significantly greater in the TRANS-fed mice than in the PUFA-and SFA-fed mice (Table  2) . Moreover, mice fed the TRANS diet developed NASH-like lesions characterized by macrovesicular steatosis (grade 3) and inflammatory infiltrate (grade 2), whereas mice fed the PUFA and SFA diets had very mild microvesicular hepatic steatosis (grade 1) with minimal inflammatory process (grade 1) (Supplemental Fig. 1B ). Fibrosis and hepatocellular ballooning were not observed in all samples and were therefore not scored.
Hepatic lipogenic gene expression. To investigate the mechanisms of development of NASH in LDLr-KO mice fed the TRANS diet, we determined the mRNA of genes involved in hepatic lipid metabolism. SREBP-1c expression was 130% and 88% higher in TRANS-fed mice than in PUFA-and SFA-fed mice, respectively. PPARg mRNA was over 4-fold and 2-fold higher in TRANS-fed mice than in PUFA-and SFA-fed mice, respectively. Conversely, MTP mRNA was 46% lower in TRANS-fed mice compared with PUFA-fed mice, suggesting a diminished liver capacity to export TG (P , 0.05). However, the groups did not differ in expression of genes related to fatty acid oxidation, PPARa, and CPT-1 ( Table 3) . Plasma lipoproteins. The plasma TG concentration in mice fed the TRANS diet was 3-fold higher than in mice fed the PUFA diet and 2-fold higher than in mice fed the SFA diet (Table 4 ). In addition, mice fed the TRANS diet had severe hypercholesterolemia; plasma cholesterol was 5-fold higher than in mice fed the PUFA diet and 2-fold higher than in mice fed the SFA diet. PUFAfed mice developed only mild hypercholesterolemia and their plasma cholesterol concentration was lower than in SFA-fed mice ( Table 4) . VLDL and LDL particles in the TRANS-fed mice had markedly elevated cholesterol and TG concentrations compared with the PUFA-and SAT-fed mice. HDL-C concentrations did not differ among the groups. However, mice fed the TRANS diet had a higher HDL TG concentration compared with mice fed the PUFA diet ( Table 4 ; Fig. 1 ).
Circulating glucose and insulin. The blood glucose concentration in feed-deprived mice in the TRANS group was higher than in the PUFA-fed mice but did not differ from the SFA-fed mice. Plasma insulin did not differ among groups. Thus, the calculated HOMA IR for mice fed the TRANS diet was higher than in mice fed the SAT and PUFA diets, indicating greater insulin resistance in the TRANS group (Table 5) .
Discussion
In this study, consumption of all 3 high-fat diets induced some degree of liver steatosis. However, compared with mice fed the PUFA and SFA diets, mice fed the TRANS diet had greater liver weight that was associated with NASH-like lesions. In agreement with another study (30) , the TRANS diet intake elicited increased transcription of genes involved in liver fat synthesis such as PPARg and SREBP-1c and was associated with higher hepatic cholesterol and TG concentrations compared with the PUFA and SFA diets. However, PPARa and CPT-1 mRNA were not affected in mice fed the TRANS diet, suggesting that the liver b-oxidative capacity did not differ among groups. In addition, we have shown that consumption of the TRANS diet decreased the MTP mRNA compared with the PUFA diet. This effect could be implicated in a reduction or insufficient transfer of TG to nascent ApoB particles and thereby reduced (impaired) VLDL assembly and secretion. This role of MTP is well established in the literature (31) and absence of MTP activity is demonstrated clinically in abetalipoproteinemia (32) . Varied rodent models of NAFLD demonstrate histological evidence of hepatic steatosis. Nevertheless, features of NASH that should include ballooning hepatocyte degeneration or inflammatory infiltrate in addition to hepatic steatosis (24) are less frequently demonstrated (25) . In the present study, LDLr-KO mice fed 3 variations of a high-fat diet developed NAFLD. However, only the TRANS diet consumption induced NASHlike lesions, characterized by steatosis and mixed lobular inflammatory infiltrate.
TRANS-fed mice had greater cholesterol and TG concentrations in VLDL and LDL particles compared with the PUFA-and SFA-fed mice. Moreover, compared with PUFA-fed mice, TRANSfed mice had more TG in the HDL particles. TG-enriched HDL particles are good substrates for hepatic lipase, the enzyme responsible for the HDL catabolism (33) . Greater enzyme activity can reduce HDL and promote the proatherogenic lipoprotein pattern associated with trans fatty acid consumption.
Our data show that mice fed the TRANS diet gained less weight than mice fed the PUFA diet and this was likely due to reduced subcutaneous and epididymal fat. This result might be explained by a direct effect of trans fatty acids on adipose tissue lipolysis enzymes. However, elucidating mechanisms would involve measurements of enzyme activity, protein expression as related to fatty acid mobilization, and transcription factor activity such as PPARa and PPARg.
Despite the similar plasma insulin concentration found in the 3 groups, only the consumption of the TRANS diet elicited greater insulin resistance as indicated by HOMA IR . In the study by Tetri et al. (21) , animals fed a diet enriched with trans fatty acids plus fructose gained more weight than the controls, likely due to higher energy intake. However, their data cannot be compared with the current results, because mice fed the TRANS diet weighed less than the other group even with similar food intake.
Fat oxidation might be influenced by the degree of unsaturation of fatty acids, being in order linolenic.linoleic.oleic (34) . In addition, energy expenditure is greater for oleic than for linoleic and linolenic fatty acids (35) and diets enriched with SFA reduce fat oxidation and energy expenditure (36) . Nonetheless, it has also been proposed that the oxidative capacity does not differ among SFA (16:0), PUFA (18:2), and trans fatty acids (trans 18:1) (34). It is important to emphasize that in our study, all diets were made with similar amounts of oleic acid and that the TRANS, PUFA, and SFA diets were enriched, respectively, with elaidic acid (18:1-trans), linoleic acid (18:2), and palmitic acid (16:0), which appear to have similar oxidative capacities (34) .
In a previous study, mice fed a high-fat diet enriched with (n-3) PUFA developed mild hepatic steatosis but had preserved mitochondrial b-oxidation and phosphorylation (37) , supporting that the consumption of a high-fat diet enriched with (n-3) PUFA may cause fatty liver without mitochondrial dysfunction. In another study with mice, low amounts of trans fatty acids induced oxidative stress (30) . These findings raise the hypothesis that trans fatty acids might induce oxidative stress due to impaired mitochondrial function or increased endoplasmatic reticulum stress. Intake of conjugated linoleic acids can also lead to hepatomegaly and decreased adipose tissue mass (38, 39) . However, because our diets did not contain conjugated linoleic acids (Table 1 ), the present results may be attributed to trans fatty acids contained in the TRANS diet.
In conclusion, this study demonstrates that dietary trans fatty acids promote changes similar to human metabolic syndrome, including proatherogenic plasma lipid profiles, hepatomegaly due to fat accumulation and inflammatory NASH-like lesions, and impaired glucose tolerance. Therefore, this investigation supports other findings that intake of trans fatty acids may be deleterious for human health. 
